UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current treatment practice and outcomes. Report of the hyponatremia registry

Kidney international, 2015-07, Vol.88 (1), p.167-177

2015

Volltextzugriff (PDF)

Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion

The American journal of medicine, 2016-05, Vol.129 (5), p.537.e9-537.e23

2016

Volltextzugriff (PDF)

Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry

Canadian journal of gastroenterology & hepatology, 2018-01, Vol.2018 (2018), p.1-9

2018

Volltextzugriff (PDF)

Current Management of Hyponatremia in Acute Heart Failure: A Report From the Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (HN Registry)

Journal of the American Heart Association, 2017-08, Vol.6 (8), p.n/a

2017

Volltextzugriff (PDF)

Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results

Contraception (Stoneham), 2021-03, Vol.103 (3), p.137-143

2021

Volltextzugriff (PDF)

Hyponatremia in Cirrhosis and End-Stage Liver Disease: Treatment with the Vasopressin V2-Receptor Antagonist Tolvaptan

Digestive diseases and sciences, 2012-11, Vol.57 (11), p.2774-2785

2012

Volltextzugriff (PDF)

The emerging role of obesity in short-acting hormonal contraceptive effectiveness

Contraception (Stoneham), 2018-05, Vol.97 (5), p.371-377

2018

Volltextzugriff (PDF)

The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients

BMC cancer, 2016-07, Vol.16 (1), p.564-564, Article 564

2016

Volltextzugriff (PDF)

Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT‐1 and SALT‐2 trials

Cancer medicine (Malden, MA), 2017-04, Vol.6 (4), p.723-729

2017

Volltextzugriff (PDF)

Patterns of treatment and correction of hyponatremia in intensive care unit patients

Journal of critical care, 2015-10, Vol.30 (5), p.1072-1079

2015

Volltextzugriff (PDF)

Smart materials use in active disassembly

Assembly automation, 2012-01, Vol.32 (1), p.8-24

2012

Volltextzugriff (PDF)

Treatment of Hyponatremia in Lung Cancer Patients With Moderate to Severe Hypervolemic or Euvolemic Hyponatremia

Chest, 2016-10, Vol.150 (4), p.694A-694A

2016

Volltextzugriff (PDF)

Adhesion Evaluation of AG200-15: An Investigational Transdermal Contraceptive Delivery System

Advances in therapy, 2019-12, Vol.36 (12), p.3381-3389

2019

Volltextzugriff (PDF)

Incidence and Prognostic Importance of Hyponatremia in a Cohort of Patients With Lung Cancers

Chest, 2015-10, Vol.148 (4), p.552A-552B

2015

Volltextzugriff (PDF)

Results From the SECURE Trial, a Phase 3 Study of the AG200-15 Investigational Transdermal Contraceptive Patch [22A]

Obstetrics and gynecology (New York. 1953), 2017-05, Vol.129 (1), p.15-15S

2017

Volltextzugriff (PDF)

Hospital Management of Hyponatremia in Patients with Heart Failure: Final Report from the HN Registry

Journal of cardiac failure, 2014-08, Vol.20 (8), p.S62-S63

2014

Volltextzugriff (PDF)

Postmarketing Safety of a Levonorgestrel/Ethinyl Estradiol Contraceptive Transdermal Delivery System [A24]

Obstetrics and gynecology (New York. 1953), 2022-05, Vol.139 (1), p.7-8S

2022

Volltextzugriff (PDF)

IMPACT OF APPLICATION SITE AND BODY MASS INDEX ON ADHESION AND TOLERABILITY OF A LEVONORGESTREL/ETHINYL ESTRADIOL TRANSDERMAL CONTRACEPTIVE DELIVERY SYSTEM

Fertility and sterility, 2021-09, Vol.116 (3), p.e291-e291

2021

Volltextzugriff (PDF)

979: Clinical predictors of response to fluid restriction in the management of patients with Hyponatremia

Critical care medicine, 2013-12, Vol.41, p.A246

2013

Volltextzugriff (PDF)

Hyponatremia in Cirrhosis and End-Stage Liver Disease: Treatment with the Vasopressin V sub(2)-Receptor Antagonist Tolvaptan

Digestive diseases and sciences, 2012-11, Vol.57 (11), p.2774-2785

2012

Volltextzugriff (PDF)

Hyponatremia in Cirrhosis and End-Stage Liver Disease: Treatment with the Vasopressin V^sub 2^-Receptor Antagonist Tolvaptan

Digestive diseases and sciences, 2012-11, Vol.57 (11), p.2774

2012

Volltextzugriff (PDF)

Hyponatremia in Cirrhosis and End-Stage Liver Disease: Treatment with the Vasopressin V.sub.2-Receptor Antagonist Tolvaptan

Digestive diseases and sciences, 2012-11, Vol.57 (11), p.2774

2012

Volltextzugriff (PDF)

Incidence of hyponatremia in a cohort of patients with colorectal cancer

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.545-545

2015

Volltextzugriff (PDF)

Prognostic significance of hypervolemic or euvolemic hyponatremia in patients with lymphoma, breast, lung, or colorectal cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e17554-e17554

2015

Volltextzugriff (PDF)

Hospital Management of Hyponatremia in Patients With Heart Failure: Interim Data from a Multi-Center Registry

Journal of cardiac failure, 2012-08, Vol.18 (8), p.S94-S94

2012

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Current treatment practice and outcomes. Report of the hyponatremia registry

Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion

Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry

Current Management of Hyponatremia in Acute Heart Failure: A Report From the Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (HN Registry)

Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results

Hyponatremia in Cirrhosis and End-Stage Liver Disease: Treatment with the Vasopressin V2-Receptor Antagonist Tolvaptan

The emerging role of obesity in short-acting hormonal contraceptive effectiveness

The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients

Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT‐1 and SALT‐2 trials

Patterns of treatment and correction of hyponatremia in intensive care unit patients

Smart materials use in active disassembly

Treatment of Hyponatremia in Lung Cancer Patients With Moderate to Severe Hypervolemic or Euvolemic Hyponatremia

Adhesion Evaluation of AG200-15: An Investigational Transdermal Contraceptive Delivery System

Incidence and Prognostic Importance of Hyponatremia in a Cohort of Patients With Lung Cancers

Results From the SECURE Trial, a Phase 3 Study of the AG200-15 Investigational Transdermal Contraceptive Patch [22A]

Hospital Management of Hyponatremia in Patients with Heart Failure: Final Report from the HN Registry

Postmarketing Safety of a Levonorgestrel/Ethinyl Estradiol Contraceptive Transdermal Delivery System [A24]

IMPACT OF APPLICATION SITE AND BODY MASS INDEX ON ADHESION AND TOLERABILITY OF A LEVONORGESTREL/ETHINYL ESTRADIOL TRANSDERMAL CONTRACEPTIVE DELIVERY SYSTEM

979: Clinical predictors of response to fluid restriction in the management of patients with Hyponatremia

Hyponatremia in Cirrhosis and End-Stage Liver Disease: Treatment with the Vasopressin V sub(2)-Receptor Antagonist Tolvaptan

Hyponatremia in Cirrhosis and End-Stage Liver Disease: Treatment with the Vasopressin V^sub 2^-Receptor Antagonist Tolvaptan

Hyponatremia in Cirrhosis and End-Stage Liver Disease: Treatment with the Vasopressin V.sub.2-Receptor Antagonist Tolvaptan

Incidence of hyponatremia in a cohort of patients with colorectal cancer

Prognostic significance of hypervolemic or euvolemic hyponatremia in patients with lymphoma, breast, lung, or colorectal cancer

Hospital Management of Hyponatremia in Patients With Heart Failure: Interim Data from a Multi-Center Registry

Suchergebnisse filtern